Company Filing History:
3 out of 119 
2 out of 155 
1 out of 12,160 
Years Active: 2010-2025
Title: Innovations of Philipp Beckhove in the Field of Pharmaceutical Research
Introduction
Philipp Beckhove, an esteemed inventor based in Heidelberg, Germany, has made significant contributions to the field of pharmaceutical research. With a portfolio of five patents, Beckhove's innovative work focuses on advancing treatments for diseases associated with cellular responses, especially in the context of cancer therapy.
Latest Patents
Among his latest patents, one notable invention is a pharmaceutical combination of anti-CEACAM6 and TIM3 antibodies. This disclosure relates to a combination of two components: component A, which is the anti-CEACAM6 antibody TPP-3310, and component B, which may be an anti-TIM-3 antibody such as cobolimab, MBG-453, BMS-986258, Sym-023, LY-3321367, or INCAGN-2390. This innovative combination holds potential for enhancing therapeutic outcomes in patients.
Another significant patent involves cytotoxic T cell response modifiers. This invention addresses a compound that selectively binds to a sensory receptor or alters the expression of a sensory receptor. It provides methods for treating or preventing diseases associated with a pathological cellular cytotoxic T cell (CTL) response. Furthermore, it includes means for detecting such sensory receptors, methods for diagnosing cellular resistance to CTL responses, and strategies for identifying agents that can influence cell responses to CTLs.
Career Highlights
Philipp Beckhove has worked with prominent institutions such as the Deutsche Krebsforschungszentrum (German Cancer Research Center) and the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His research efforts have been pivotal in advancing understanding and treatment approaches for various diseases, particularly in oncology.
Collaborations
Throughout his career, Beckhove has collaborated with notable individuals such as Volker Schirrmacher and Michael Boutros. These collaborations have contributed to the development of innovative solutions and enhanced research outcomes in their respective fields.
Conclusion
Philipp Beckhove's work has made a lasting impact on pharmaceutical research, particularly in the realm of cancer treatment. His patents demonstrate a commitment to enhancing clinical outcomes and represent significant advancements in the understanding of cellular responses and therapeutic interventions. As he continues to innovate, Beckhove's contributions will undoubtedly play a critical role in shaping the future of medical research and treatment strategies.